NCT02917200View on ClinicalTrials.gov

Safety and Efficacy Study of Different DAV132 Dose Regimens in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

May 11, 2016

Primary Completion Date

December 2, 2016

Study Completion Date

December 2, 2016

Conditions

Healthy Subjects

Interventions

DRUG

Moxifloxacin

Oral route

DEVICE

DAV132

Oral route

OTHER

Negative control

Oral route

Trial Locations (1)

38610

Eurofins Optimed, Gières

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Da Volterra

INDUSTRY

NCT02917200 - Safety and Efficacy Study of Different DAV132 Dose Regimens in Healthy Volunteers | Biotech Hunter | Biotech Hunter